Cullinan Therapeutics Inc (CGEM)

Investing Cash Flow

$162.88M

TTM · Period ending: · USD

CGEM logo

CGEM Investing Cash Flow

Latest reported$162.88M
CGEM TTM Cash from Investing (-$35.40M → $162.88M)
High-resolution chart · PNG

CGEM investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cullinan Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
162,875,000
175,598,000
179,989,000
173,562,000
126,048,000
-112,465,000
-136,314,000
-100,808,000
-163,644,000
33,578,000
35,806,000
-44,274,000
-59,294,000
229,448,000
248,975,000
261,723,000
294,108,000
-161,338,000
-333,775,000
-306,473,000
-282,821,000
-116,256,000
-5,420,000
-52,245,000
-50,308,000
-62,284,500
-35,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.